ImageneBio (IMA) Change in Accured Expenses (2020 - 2024)
Historic Change in Accured Expenses for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$1.8 million.
- ImageneBio's Change in Accured Expenses rose 2546.77% to -$1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.5 million, marking a year-over-year increase of 6757.18%. This contributed to the annual value of -$2.5 million for FY2024, which is 6757.18% up from last year.
- ImageneBio's Change in Accured Expenses amounted to -$1.8 million in Q4 2024, which was up 2546.77% from $4.8 million recorded in Q3 2024.
- In the past 5 years, ImageneBio's Change in Accured Expenses ranged from a high of $4.8 million in Q3 2024 and a low of -$3.8 million during Q1 2024
- Over the past 5 years, ImageneBio's median Change in Accured Expenses value was -$271500.0 (recorded in 2020), while the average stood at -$251550.0.
- Per our database at Business Quant, ImageneBio's Change in Accured Expenses skyrocketed by 948000.0% in 2021 and then plummeted by 30136.52% in 2023.
- ImageneBio's Change in Accured Expenses (Quarter) stood at $1.3 million in 2020, then grew by 28.51% to $1.7 million in 2021, then tumbled by 134.57% to -$586000.0 in 2022, then crashed by 301.37% to -$2.4 million in 2023, then rose by 25.47% to -$1.8 million in 2024.
- Its last three reported values are -$1.8 million in Q4 2024, $4.8 million for Q3 2024, and -$1.7 million during Q2 2024.